LSTA Projected Dividend Yield

Com Par $0.00001/Lisata Therapeutics Inc ( NASDAQ : LSTA )

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. Co. is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are not affected. LSTA1 also has the potential to modify the tumor microenvironment (TME).

20 YEAR PERFORMANCE RESULTS